Taysha Gene Therapies Inc. (TSHA)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 96
-0.01
-0.1675%
$
1.43B Market Cap
- P/E Ratio
- Div Yield
2.85M Volume
-0.41 Eps
$ 5.97
Previous Close 
Want to track TSHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taysha Gene Therapies Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 MICHAEL DE LUZ Williams & Novak, LLC | 45,000 | $79,650 | $271,125 | $191,475 | 240.4% |
 Raymond Debbane Siren, L.L.C. | 8.83M | $18.62M | $52.94M | $34.32M | 184.36% |
| MA Marie-Andree Alain Federation des caisses Desjardins du Quebec | 5,000 | $22,350 | $30,025 | $7,675 | 34.34% |
 Mark Schafer Police & Firemen's Retirement System of New Jersey | 57,168 | $116,595.23 | $337,862.88 | $221,267.65 | 189.77% |
| BGI B Group Inc. B Group Inc. | 1.8M | $3.33M | $10.75M | $7.42M | 222.56% |
| CW Chung Wu Chung Wu Investment Group LLC | 2,000 | $11,000 | $12,051.4 | $1,051.4 | 9.56% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 6,128 | $13,277.68 | $36,308.4 | $23,030.72 | 173.45% |
